BeStock  
Stocks › Biotechnology › RXRX

Recursion Pharmaceuticals RXRX

US equityMarket cap rank #2863BiotechnologyAI medical concept stocks
$2.45 −$0.27 (-9.93%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $2.51 +2.39%
Open$2.63
Prev close$2.72
Day range$2.44 – $2.76
Volume29.88M
Market cap$1.53B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$6.63+170.6% vs. price
  • Buy 50%
  • Hold 50%
Low $5.90Now $2.45Avg $6.63High $8.00

Recent rating changes

The last 20 actions on file set price targets from $5.30 to $10.00, averaging $6.71.

DateFirmRatingTarget
4 Nov 2026 BofA Securities HOLD $6.00
19 Oct 2026 Needham BUY $8.00
16 Oct 2026 BofA Securities HOLD $6.00
16 Oct 2026 Morgan Stanley HOLD $5.90
21 Sep 2026 BofA Securities HOLD –
15 Sep 2026 J.P. Morgan BUY –
17 Aug 2026 Morgan Stanley HOLD $5.30
12 Aug 2026 BofA Securities HOLD $6.00
7 Aug 2026 BofA Securities HOLD $6.00
5 Aug 2026 TD Cowen HOLD –
5 Aug 2026 Needham BUY $8.00
14 May 2026 Morgan Stanley HOLD $5.50
13 May 2026 BofA Securities HOLD $6.00
7 May 2026 BofA Securities HOLD $6.00
7 May 2026 Needham BUY $8.00
6 May 2026 TD Cowen HOLD –
30 Apr 2026 J.P. Morgan BUY $10.00
14 Apr 2026 Needham BUY $8.00
25 Feb 2026 TD Cowen HOLD –
25 Feb 2026 BofA Securities HOLD $6.00

Discussion

No comments yet — be the first to weigh in on RXRX.

Sign in to join the discussion.

Scroll to Top